IMPACT OF ADJUNCT TREATMENT WITH MAITAKE-SX FRACTION ON GLYCEMIC CONTROL

舞茸-SX 组分辅助治疗对血糖控制的影响

• 批准号: 7606866
• 负责人: ALAN SEGAL
• 金额: $ 2.48万
• 依托单位: UNIVERSITY OF NEW MEXICO
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7606866
• 关键词: Blood Glucose; Computer Retrieval of Information on Scientific Projects Database; Diabetes Mellitus; Fasting; Funding; Grant; Institution; Maitake; Non-Insulin-Dependent Diabetes Mellitus; Patients; Purpose; Research; Research Personnel; Resources; Source; Testing; United States National Institutes of Health; glucose tolerance; glycemic control; improved

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to test the hypothesis that that the product, Maitake-SX fraction, will decrease fasting blood glucose and improve glucose tolerance in patients with type 2 diabetes, without a significant impact on patients without diabetes.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目及 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 本研究的目的是检验以下假设：舞茸-SX 级分产品将降低 2 型糖尿病患者的空腹血糖并改善糖耐量，而对非糖尿病患者没有显着影响。